JP2005504029A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504029A5
JP2005504029A5 JP2003515240A JP2003515240A JP2005504029A5 JP 2005504029 A5 JP2005504029 A5 JP 2005504029A5 JP 2003515240 A JP2003515240 A JP 2003515240A JP 2003515240 A JP2003515240 A JP 2003515240A JP 2005504029 A5 JP2005504029 A5 JP 2005504029A5
Authority
JP
Japan
Prior art keywords
methoxybenzylamino
diphenylmethyl
azabicyclo
octane
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003515240A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504029A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2002/002847 external-priority patent/WO2003009848A1/en
Publication of JP2005504029A publication Critical patent/JP2005504029A/ja
Publication of JP2005504029A5 publication Critical patent/JP2005504029A5/ja
Withdrawn legal-status Critical Current

Links

JP2003515240A 2001-07-20 2002-07-15 犬の好ましくない行動を改善するためのｎｋ−１受容体アンタゴニストの使用 Withdrawn JP2005504029A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30669201P 2001-07-20 2001-07-20
PCT/IB2002/002847 WO2003009848A1 (en) 2001-07-20 2002-07-15 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses

Publications (2)

Publication Number Publication Date
JP2005504029A JP2005504029A (ja) 2005-02-10
JP2005504029A5 true JP2005504029A5 (https=) 2005-09-22

Family

ID=23186426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003515240A Withdrawn JP2005504029A (ja) 2001-07-20 2002-07-15 犬の好ましくない行動を改善するためのｎｋ−１受容体アンタゴニストの使用

Country Status (13)

Country Link
US (1) US20030139443A1 (https=)
EP (1) EP1411946A1 (https=)
JP (1) JP2005504029A (https=)
KR (1) KR20040029375A (https=)
CN (1) CN1529600A (https=)
CA (1) CA2448722A1 (https=)
CZ (1) CZ200434A3 (https=)
HU (1) HUP0401154A2 (https=)
IL (1) IL158990A0 (https=)
PL (1) PL367944A1 (https=)
SK (1) SK252004A3 (https=)
WO (1) WO2003009848A1 (https=)
ZA (1) ZA200308991B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2554823A1 (en) 2004-01-30 2005-09-09 Pfizer Products Inc. Nk-1 receptor antagonists to improve anesthesia recovery
LT1713504T (lt) 2004-01-30 2017-09-11 Zoetis Services Llc Antimikrobinis konservantas, skirtas multi-dozinėms kompozicijoms, panaudojant beta-ciklodekstrinus, skirtas skystoms vaisto formoms
CA2564751A1 (en) * 2004-04-30 2005-11-24 Schering Corporation Neuropeptide receptor modulators
CN114403042A (zh) * 2021-12-13 2022-04-29 深圳先进技术研究院 一种大动物焦虑症动物模型

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
US5232929A (en) * 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
AU657552B2 (en) * 1991-05-31 1995-03-16 Pfizer Inc. Quinuclidine as substance P antagonists
DE69213451T2 (de) * 1991-06-20 1997-01-09 Pfizer Inc., New York Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen
ATE166650T1 (de) * 1993-03-04 1998-06-15 Pfizer Spiroazacyclischderivate als substanz p antagonisten
DK0623344T3 (da) * 1993-05-04 2000-12-18 Ceva Sante Animale Anvendelse af selegilin i veterinær medicin
IL109646A0 (en) * 1993-05-19 1994-08-26 Pfizer Heteroatom substituted alkyl benzylamino-quinuclidines
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US6083943A (en) * 1993-09-17 2000-07-04 Pfizer Inc Substituted azaheterocyclecarboxylic acid
EP1209157A1 (en) * 1993-09-17 2002-05-29 Pfizer Inc. Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
US5854262A (en) * 1993-10-07 1998-12-29 Pfizer Inc. Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
PE45195A1 (es) * 1994-03-03 1996-01-17 Boehringer Ingelheim Kg Derivado de aminoacido, procedimiento para su preparacion y composicion farmaceutica que lo contiene
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
ES2229259T3 (es) * 1995-01-12 2005-04-16 Glaxo Group Limited Derivados de piperidina con actividad antagonista de taquiquinina.
US5990125A (en) * 1996-01-19 1999-11-23 Pfizer Inc. NK-1 receptor antagonists for the treatment of cancer
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
DE69736390T2 (de) * 1996-10-07 2007-07-26 Merck Sharp & Dohme Ltd., Hoddesdon Zns-penetrierende nk-1 rezeptorantagonisten als antidepressivum und / oder anxiolytikum
IL130223A (en) * 1996-12-19 2005-09-25 Aventis Pharma Inc Heterocyclic substituted pyrrolidine amide derivatives, process for their preparation and pharmaceutical compositions containing them
US6156749A (en) * 1997-12-01 2000-12-05 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating movement disorders
JP4669095B2 (ja) * 1999-07-19 2011-04-13 太陽化学株式会社 ペットの問題行動抑制組成物
CA2280309C (en) * 1999-08-13 2007-05-08 William Norton Milgram Use of adrafinil to treat behavioral problems in aged canines
CA2324813A1 (en) * 1999-11-10 2001-05-10 Susan Beth Sobolov-Jaynes Combination treatment for depression and anxiety
US20020049211A1 (en) * 2000-09-06 2002-04-25 Sobolov-Jaynes Susan Beth Combination treatment for depression and anxiety

Similar Documents

Publication Publication Date Title
JP4221221B2 (ja) Ｃｂ１受容体アンタゴニストおよびシブトラミンの組み合わせ、それらからなる医薬組成物、および肥満の治療におけるそれらの使用
Ogata¹ et al. Selective serotonin reuptake inhibitors
RU2003114752A (ru) Лечение желудочно-кишечных стромальных опухолей
RU2009114747A (ru) Производные пиррола, применимые в лечении цитокин-опосредованных заболеваний
JP2008545647A5 (https=)
WO2010020585A1 (en) Serotonin reuptake inhibitors for the treatment of rett syndrome
CA2458855A1 (en) Composition for treating parkinson's disease containing a cb1 receptor antagonist and a product activating dopaminergic neurotransmission in the brain
KR20210107729A (ko) 운동 장애의 치료
JP2003012557A (ja) 不安及びうつ病のための多剤併用治療
JP2005504029A5 (https=)
US20030139443A1 (en) Use of tachykinin antagonists, including NK-1 receptor antagonists, to modify unwanted behavior in dogs, cats and horses
RU2005135649A (ru) Комбинации пароксетина и 4-(s)-(4-ацетилпиперазин-1-ил)-2-(r)-(4-фтор-2-метилфенил)пиперидин-1-карбоновой кислоты [1-(r)-(3, 5-бис-трифторметилфенил)этил]метиламида для лечения депрессии и/или тревоги
JP2023501186A (ja) グルタミン酸２ｂ受容体拮抗薬及びシグマ受容体作動薬の鎮咳薬としての使用
CN1474691A (zh) 联合的5－ht1a激动剂和5－羟色胺再摄取抑制剂的新用途
Ferraro et al. Evaluation of three chemical immobilization protocols in golden‐headed lion tamarins (Leontopithecus chrysomelas) undergoing vasectomy surgery
KR20230159526A (ko) 타시피미딘 제형 및 이의 용도
ES2284711T3 (es) Tiagabina para el tratamiento de neuropatia diabetica.
JP2024541315A (ja) 中枢性低換気に関連する状態を治療するための方法および組成物
Carter Benefits of medicating patients for veterinary visits
US20060173071A1 (en) Mast cell stabilizers used to inhibit laminitis
EP1505976B1 (en) Synergistic combination of an opioid analgesic and a nsaid
Friton et al. Investigation of the clinical efficacy, safety and palatability of meloxicam (Metacam®) treatment in horses with musculosceletal disorders
JO et al. Use of carbamate compound for preventing or treating trigeminal neuralgia
JP2002501046A5 (https=)
Bidwell How to manage the pain of laminitis in the field.